Brandi Glanville Details 18-Hour IV Regimen and Benign Tumor Diagnosis in Health Update
Brandi Glanville disclosed that she is undergoing an 18-hour daily intravenous antibiotic regimen to treat a benign tumor on her jaw and ongoing facial parasite issues. The 53-year-old reality star stated that the treatment has caused significant weight loss, describing herself as 'so skinny' and feeling 'like death.' She explained that she must self-administer part of the therapy at home before a nurse arrives for additional infusions. Glanville noted that she has been battling these health complications for three years, linking the condition to ruptured breast implants that clogged her lymph nodes. She expressed frustration at the inability to surgically remove the tumor, stating that she is 'still fighting to get whatever is in my face OUT.' The update follows previous reports of her facial parasite recurrence and highlights the physical toll of her prolonged medical treatment.
Key points
- Glanville is receiving an 18-hour daily IV regimen, including Imipenem, to treat a benign tumor on her jaw and facial parasites.
- She reported significant weight loss, stating she feels and looks 'like death' due to the intensive treatment.
- The 53-year-old must self-administer part of the IV therapy at home before a nurse arrives for additional infusions.
- Glanville linked her condition to ruptured breast implants that clogged her lymph nodes, causing infections that persisted for three years.
- She expressed frustration that she cannot surgically remove the tumor, describing the current situation as an unwanted lifestyle change.
Background
Glanville has been publicly discussing her health struggles for several months, including a June 2026 podcast appearance where she mentioned the three-year duration of her facial parasite issue. Earlier this year, she told TMZ that her breast implants had ruptured, spreading silicone into her lymph nodes and causing infections. This update follows a broader cultural conversation in mid-2026 regarding diet culture and the trivialization of illness-driven weight loss, as seen in social media reactions to cyclospora outbreaks. While those discussions focused on public humor regarding parasites, Glanville’s case highlights the severe medical reality and physical toll of such conditions for individuals undergoing long-term treatment.
Why it matters
This update provides a detailed look at the physical impact of prolonged medical treatments for complex conditions involving lymphatic and facial issues. It underscores the challenges faced by individuals managing chronic health problems that require intensive, daily interventions. Glanville’s transparency about her regimen and the resulting weight loss offers insight into the realities of living with such conditions, contrasting with public discussions that often trivialize illness-related weight changes. The case also highlights the intersection of past cosmetic procedures and long-term health complications, a topic of growing interest in medical and celebrity circles.
What to watch
Glanville has not disclosed the specific nature of the condition in her face, stating she is 'not ready to share that part just yet.' She continues to undergo the 18-hour IV regimen and is working with a nurse for additional treatments. Her next steps likely involve ongoing medical monitoring and potential future updates on the progress of her treatment. The public may await further details as she continues to document her health journey through social media and her podcast.
Want the full story? Read the original reporting
Read on E! News